Alphamab Oncology (9966.HK)
HKD 3.54
(-1.67%)
HKD 3.54
(-1.67%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -202.83 Million | -300.3 Million | -320.6 Million | -347.18 Million | -225.49 Million | -93.87 Million |
| Net Income | -210.59 Million | -325.72 Million | -412.41 Million | -427.76 Million | -832.74 Million | -202.63 Million |
| Depreciation & Amortization | 69.11 Million | 55.18 Million | 41.1 Million | 30.12 Million | 11.77 Million | 6.56 Million |
| Deferred income taxes | - | 1.32 Million | 13.02 Million | -14.32 Million | 106 Thousand | -263 Thousand |
| Stock-based compensation | 15.38 Million | 13.29 Million | 8.16 Million | 32.72 Million | 91.02 Million | 263 Thousand |
| Change in working capital | 8 Million | -14.61 Million | -21.19 Million | -18.4 Million | -12.2 Million | -3.32 Million |
| Other non-cash items | -64.09 Million | -29.77 Million | 50.71 Million | 50.45 Million | 516.54 Million | 105.52 Million |
| Investing Cash Flow | -18.1 Million | 850.75 Million | 574.26 Million | -1.52 Billion | -654.01 Million | -72.11 Million |
| Investments in PPE | -36.18 Million | -129.65 Million | -158.11 Million | -90.82 Million | -171.37 Million | -73.11 Million |
| Acquisitions | - | -942.05 Million | -675.21 Million | 1.46 Billion | - | - |
| Investment purchases | -638.71 Million | -1.23 Billion | -1.56 Billion | -2.46 Billion | -1.14 Billion | -48.9 Million |
| Sales/Maturities of investments | 599.19 Million | 2.17 Billion | 2.24 Billion | 997.5 Million | 647.1 Million | 49.5 Million |
| Other Investing Activities | 18.07 Million | 980.4 Million | 732.38 Million | -1.43 Billion | 19.36 Million | 408 Thousand |
| Financing Cash Flow | 218.07 Million | -310.9 Million | 363.9 Million | 186.57 Million | 2.11 Billion | 798.8 Million |
| Debt repayment | -75 Million | -692.95 Million | -313.97 Million | -141.5 Million | -12.68 Million | -67.52 Million |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 321.03 Million | 253 Thousand | 345 Thousand | 250.25 Million | 1.64 Billion | 7000.00 |
| Other Financing Activities | 305.96 Million | 381.79 Million | 677.52 Million | 77.82 Million | 480.07 Million | 866.31 Million |
| Accounts receivables | 8.35 Million | -7.88 Million | -7.6 Million | - | -33.17 Million | -17.04 Million |
| Accounts payables | - | -21.13 Million | 1.25 Million | - | 33.17 Million | 17.04 Million |
| Inventory | -14.11 Million | -6.72 Million | -13.58 Million | -18.4 Million | -18.85 Million | -3.58 Million |
| Other working capital | 15.54 Million | 21.13 Million | -1.25 Million | -16.78 Million | 6.64 Million | 257 Thousand |
| Cash at beginning of period | 1.06 Billion | 803.3 Million | 185.32 Million | 1.86 Billion | 633.71 Million | 57 Thousand |
| Cash at end of period | 1.08 Billion | 1.06 Billion | 803.3 Million | 185.32 Million | 1.86 Billion | 633.71 Million |
| Capital Expenditure | -36.18 Million | -129.65 Million | -158.11 Million | -90.82 Million | -171.37 Million | -73.11 Million |
| Effect of forex changes on cash | 19.67 Million | 26.33 Million | 419 Thousand | 1.73 Million | -316 Thousand | -8.69 Million |
| Net cash flow / Change in cash | 16.79 Million | 265.88 Million | 617.98 Million | -1.68 Billion | 1.23 Billion | 633.65 Million |
| Free Cash Flow | -239.02 Million | -429.95 Million | -478.71 Million | -438 Million | -396.87 Million | -166.99 Million |
| Breakdown | 2024 Q2 | 2023 FY | 2023 Q4 | 2023 Q2 | 2022 FY | 2022 Q4 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -44.89 Million | -210.59 Million | -170.73 Million | -39.86 Million | -325.72 Million | -178.41 Million |
| Depreciation & Amortization | 37.29 Million | 69.11 Million | 36.76 Million | 32.35 Million | 55.18 Million | 31.91 Million |
| Deferred income taxes | - | - | - | 2.31 Million | 1.32 Million | -18.4 Million |
| Stock-based compensation | 1.11 Million | 15.38 Million | 9.24 Million | 4.04 Million | 13.29 Million | 8.07 Million |
| Change in working capital | 3.16 Million | 8 Million | -3.4 Million | 13.2 Million | -14.61 Million | 4.55 Million |
| Other non-cash items | -42.66 Million | -64.09 Million | -1.07 Million | -83.37 Million | -29.77 Million | -20.4 Million |
| Investing Cash Flow | 37.94 Million | -18.1 Million | 138.36 Million | -156.47 Million | 850.75 Million | 413.36 Million |
| Investments in PPE | -4.86 Million | -36.18 Million | -14.06 Million | -22.11 Million | -129.65 Million | -64.76 Million |
| Acquisitions | - | - | - | - | -942.05 Million | - |
| Investment purchases | - | -638.71 Million | - | - | -1.23 Billion | - |
| Sales/Maturities of investments | - | 599.19 Million | - | - | 2.17 Billion | - |
| Other Investing Activities | 42.81 Million | 18.07 Million | 152.43 Million | -134.35 Million | 980.4 Million | 478.12 Million |
| Financing Cash Flow | 58.08 Million | 218.07 Million | -39.55 Million | 257.62 Million | -310.9 Million | -186.15 Million |
| Debt repayment | -62.53 Million | -75 Million | - | -61.71 Million | -692.95 Million | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | 321.03 Million | - | - | 253 Thousand | - |
| Other Financing Activities | -4.45 Million | 305.96 Million | -39.55 Million | 319.34 Million | 381.79 Million | -186.15 Million |
| Accounts receivables | -6.03 Million | 8.35 Million | 16.42 Million | -8.06 Million | -7.88 Million | -650 Thousand |
| Accounts payables | - | - | - | - | -21.13 Million | - |
| Inventory | 13.58 Million | -14.11 Million | -15.81 Million | 1.7 Million | -6.72 Million | 10.98 Million |
| Other working capital | -4.38 Million | 15.54 Million | -4.01 Million | 19.56 Million | 21.13 Million | -5.78 Million |
| Cash at beginning of period | 1.08 Billion | 1.06 Billion | 1.13 Billion | 1.06 Billion | 803.3 Million | 977.36 Million |
| Cash at end of period | 1.14 Billion | 1.08 Billion | 1.13 Billion | 1.13 Billion | 1.06 Billion | 1.06 Billion |
| Capital Expenditure | -4.86 Million | -36.18 Million | -14.06 Million | -22.11 Million | -129.65 Million | -64.76 Million |
| Effect of forex changes on cash | 4.16 Million | 19.67 Million | -19.92 Million | 39.59 Million | 26.33 Million | 18.88 Million |
| Net cash flow / Change in cash | 54.2 Million | 16.79 Million | - | 67.11 Million | 265.88 Million | 91.82 Million |
| Free Cash Flow | -50.85 Million | -239.02 Million | -143.26 Million | -95.75 Million | -429.95 Million | -219.03 Million |
GRL
EW
PLAOU
MRMD
HUYA
9900